» Articles » PMID: 1718825

Immunohistochemical Localization of Epidermal Growth Factor Receptor in a Human Epiretinal Membrane

Overview
Specialty Ophthalmology
Date 1991 Jan 1
PMID 1718825
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Cell growth in proliferative vitreoretinopathy (PVR) is activated by naturally occurring mitogenic substances; thus, growth factors seem to play an important role in PVR. Cell activation by growth factors requires the presence of specific cell-bound receptors by which the mitogenic signal is transmitted. Using the indirect immunoperoxidase method, we investigated frozen sections of 15 epiretinal membranes in PVR for the presence of epidermal growth factor receptor (EGFR), which is commonly utilized by epidermal growth factor (EGF) and transforming growth factor-alpha (TGF-alpha). This receptor could be localized only in one epiretinal membrane. The receptor-bearing cells stained positively for vimentin, cytokeratin, and macrophage marker Ki-M7, indicating that they most probably correspond to transformed macrophages. They stained negatively for desmin and glial fibrillary acidic protein. The cells were embedded in a fibronectin-positive intercellular matrix and were in an actively proliferating state as demonstrated by positive staining for the nuclear proliferation marker Ki-67. We propose that EGFR might be expressed only in certain as yet undefined stages of PVR.

Citing Articles

YM155 inhibits retinal pigment epithelium cell survival through EGFR/MAPK signaling pathway.

Li T, Zhang H, Meng J, Yuan B, Lin W, Feng Y Int J Ophthalmol. 2021; 14(4):489-496.

PMID: 33875937 PMC: 8025172. DOI: 10.18240/ijo.2021.04.02.


Protein tyrosine phosphatase 1B regulates migration of ARPE-19 cells through EGFR/ERK signaling pathway.

Du Z, Hu L, Zhao G, Wang Q, Xu Q, Jiang N Int J Ophthalmol. 2015; 8(5):891-7.

PMID: 26558197 PMC: 4630995. DOI: 10.3980/j.issn.2222-3959.2015.05.07.


Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.

Lesnik Oberstein S, Byun J, Herrera D, Chapin E, Fisher S, Lewis G Mol Vis. 2011; 17:1794-805.

PMID: 21750605 PMC: 3133557.


Glucosamine inhibits epidermal growth factor-induced proliferation and cell-cycle progression in retinal pigment epithelial cells.

Liang C, Tai M, Chang Y, Chen Y, Chen C, Chien M Mol Vis. 2010; 16:2559-71.

PMID: 21151603 PMC: 3000239.


[Vitreal-induced RPE cell traction. Investigation of pathological vitreous samples in an in vitro contraction model].

Beutel J, Luke M, Bartz-Schmidt K, Grisanti S Ophthalmologe. 2008; 106(10):893-8.

PMID: 18830601 DOI: 10.1007/s00347-008-1847-3.


References
1.
Schreiber A, Winkler M, Derynck R . Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986; 232(4755):1250-3. DOI: 10.1126/science.2422759. View

2.
Ho P, Davis W, Elliott J, Cohen S . Kinetics of corneal epithelial regeneration and epidermal growth factor. Invest Ophthalmol. 1974; 13(10):804-9. View

3.
Cohen S . Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem. 1962; 237:1555-62. View

4.
Carpenter G, Cohen S . 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J Cell Biol. 1976; 71(1):159-71. PMC: 2109737. DOI: 10.1083/jcb.71.1.159. View

5.
Gerdes J, Schwab U, Lemke H, STEIN H . Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer. 1983; 31(1):13-20. DOI: 10.1002/ijc.2910310104. View